COC Use and Ovarian Cancer Survival: What the Data Reveals

Ovarian cancer ranks as the third most common gynecological cancer worldwide, after cervical and uterine types. For decades, researchers have noted that birth control pills may lower the risk of developing this disease. But does taking them affect survival after a diagnosis? A recent study from Ethiopia set out to find out.

Researchers tracked 436 women with ovarian cancer at hospitals in Addis Ababa. About a quarter of them had used combined oral contraceptives before their diagnosis, while the rest had not. Scientists used survival charts and statistical models to compare outcomes between the two groups.

Women who had used birth control pills before their cancer diagnosis had a much lower risk of dying. The death rate was about 5.6 per 1,000 person-years for users, compared to 14.0 for non-users. After five years, 66 percent of users were still alive, versus only 38 percent of non-users. Even after accounting for other health factors, the adjusted risk of death was roughly 37 percent lower for pill users. The typical survival time for the whole group was about 4 years and 2 months.

The study design looked back at patient records, which is called a retrospective cohort. Researchers followed the women for a median of nearly 42 months. Findings suggest that prior pill use might be linked to better outcomes, but scientists say more research is needed to understand why. These results add to a growing body of evidence that hormonal contraceptives may have complex effects on cancer survival.